30/10/20 -"Preliminary FY19/20 earnings came in below our expectations. In our view, lower sales in the cash cow microsurgery segment and aggressive investment in digitalisation could have been the culprits. ..."
Pages
65
Language
English
Published on
30/10/20
You may also be interested by these reports :
10/05/24
While the 2023 EPS benefitted from material deferred tax income, we have moderated our earnings estimates for 2024-25 owing to high interest rates ...
10/05/24
Fresenius reported Q1 figures that exceeded the consensus, with revenues increasing by 0.3%, adjusted EBIT by 4.5%, net income from continuing ...
09/05/24
Smith & Nephew reported marginally softer than expected Q1 24 numbers. The weakness was largely attributable to US implants and areas within wound ...
08/05/24
CZM reported soft Q2 results with both sales and adjusted EBIT missing the street’s expectations. The mid-single-digit sales decline was due to ...